The right treatment depends on medical history, safety, FDA approval status, access, tolerance, side effects, muscle-preservation needs, metabolic risk, and long-term planning
The groundbreaking 2021 clinical trial of semaglutide still found that almost 14% of participants failed to even lose 5% of their body weight, even after taking the drug for more than one year
Compounded semaglutide options may cost less, but are not FDA-approved
Switching medications If semaglutide side effects remain unmanageable despite dose adjustments, switching to an alternative GLP-1 receptor agonist or to tirzepatide may be appropriate
Understanding your genetic peptide sensitivity empowers personalized treatment timing that aligns with your biology rather than a one-size-fits-all schedule
Winner: semaglutide / Wegovy Round 5: Cost At the time of this article, cash prices at pharmacies are as follows: Ozempic: ~$900 / month Wegovy: ~$1,500 / month Zepbound: ~$1,100 / month Ozempic is not covered by insurance if used for weight loss, but because of the way the pen is manufactured, it is possible to get 8 doses out of 1 pen, albeit at a lower dose than those found in Wegovy
